References |
|
- Stone, R: Stalin's forgotten cure. Science 2002, 298:728731.[PubMed][Full
Text]
- Larocca, D, Burg, MA, Jensen-Pergakes,
K, Ravey, EP, Gonzalez, AM, & Baird, A: Evolving phage vectors for cell targeted gene
delivery. Curr Pharm
Biotechnol 2002, 3:4557.[PubMed]
- Weber-Dabrowska, B, Mulczyk, M, &
Górski, A: Bacteriophage therapy of
bacterial infections: an update of our institute's
experience. Arch Immunol Ther
Exp 2000, 48:547551.[PubMed]
- Sulakvelidze, A, Alavidze, Z, &
Morris, JG: Bacteriophage
therapy. Antimicrob Agents
Chemother 2001, 45:649659.[PubMed][Free
Full Text]
- Merril, CR, Friedman, TB, Attallah,
AFM, Geier, MR, Krell, K, & Yarkin, R: Isolation of bacteriophages from commercial
sera. In Vitro 1972, 8:9193.[PubMed]
- Gantzer, C, Henny, J, &
Schwartzbrod, L: Bacterioides
fragilis and Escherichia coli bacteriophages in human
faeces. Int J Hyg Environ
Health 2002, 205:324328.[PubMed]
- Bachrach, G, Leizerovici-Zigmond, M,
Zlotkin, A, Naor, R, & Steiberg, D: Bacteriophage isolation from human saliva.
Lett Appl Microbiol 2003, 36:5053.[PubMed][Full
Text]
- Kamme, C: Antibodies against staphylococcal bacteriophages
in human sera. I. Assay of antibodies in healthy individuals and
in patients with staphylococcal infections. Acta Pathol Microbiol Scand (B) Microbiol
Immunol 1973, 81:741748.[PubMed]
- Hedstrom, SA & Kamme, C:
Antibodies against staphylococcal
bacteriophages in human sera. II. Assay of antibodies in
exacerbation and regression of chronic staphylococcal
osteomyelitis. Acta Path Microbiol
Scand (B) 1973, 81:749752.[PubMed]
- Kucharzewicz-Krukowska, A & Slopek,
S: Immunogenic effects of
bacteriophage in patients subjected to phage therapy. Arch Immun Ther Exp 1987, 35:553561.
- Ochs, HD, Davis, SD, & Wedgwood,
RJ: Immunologic responses to
bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest 1971, 50:25591568.[PubMed]
- Sullivan, JL, Ochs, HD, Schiffman, G,
Hammerschlag, MR, Miser, J, Vicinsky, E, & Wedgwood,
RJ: Immune response after
splenectomy Lancet 1978, 18:178181.[PubMed]
- Fogelman, I, Davey, V, Ochs, HD,
Elashoff, M, Feinberg, MB, Mican, J, Siegel, JP, Sneller, M, &
Lane, HC: Evaluation of CD4+ T cell
function in vivo in HIV-infected patients as measured by
bacteriophage phi 174 immunization. J Infect Dis 2000, 182:435441.[PubMed][Full
Text]
- Shearer, WT, Lugg, DJ, Rosenblatt, HM,
Nickoll, PM, Sharp, RM, Reuben, JM, & Ochs, HD: Antibody responses to bacteriophage phi X-174 in
human subjects exposed to the antarctic wind – over model of
spaceflight J Allergy Clin
Immunol 2001, 107:1920.[PubMed][Full
Text]
- Rubinstein, A, Mizrachi, Y, Bernstein,
L, Shliozberg, J, Goldener, M, Liu, GQ, & Ochs, DH:
Progressive specific immune attrition after
primary, secondary and tertiary immunizations with bacteriophage
phi X 174 in asymptomatic HIV-1 infected patients. AIDS 2000,
14:F5562.[PubMed][Full
Text]
- Bohnsack, J, Ochs, HD, Wedgewood, RJ,
& Heller, SR: Antibody to
bacteriophage phi X 174 synthesized by cultured human peripheral
blood lymphocytes. Clin Exp
Immunol 1985, 59:673678.[PubMed]
- Wenger, SL, Turner, JH, &
Petricciani, JC: The cytogenetic,
proliferative and viability effects of four bacteriophages on
human lymphocytes. In Vitro
1978, 14:543549.[PubMed]
- Merril, CR, Geier, MR, &
Petricciani, JC: Bacterial virus gene
expression in human cells. Nature 1971, 233:398400.[PubMed]
- Di Giovine, M, Salone, B, Martina, Y,
Amati, V, Zambruno, G, Cundari, E, & Failla, CM: Saggio Binding properties, cell delivery, and gene
transfer of adenoviral penton base displaying
bacteriophage. Virology
2001, 282:102112.[PubMed][Full
Text]
- Lederberg, J: Smaller fleas... ad infinitum: therapeutic
bacteriophage redux. Proc Nat Acad
Sci USA 1996, 93:31673168. [ Free Full text
in PMC]
- Bloch, H: Experimental investigation on the relationships
between bacteriophages and malignant tumors. Arch Virol 1940, 1:481496(in German)
- Kañtoch, M & Mordarski, M:
Binding of bacterial viruses by cancer cells
in vitro. Post Hig Med Dosw
1958, 12:191192(in
Polish)
- Kañtoch, M: Studies on phagocytosis of bacterial
viruses. Arch Immun Ther Exp
1958, 6:6384(in
Polish)
- Lafrenie, RM, Lee, SF, Hewlett, IK,
Yamada, KM, & Dhawan, S: Involvement of integrin alphavbeta3 in the
pathogenesis of human immunodeficiency virus type 1 infection in
monocytes. Virology 2002, 297:3138.[PubMed][Full
Text]
- Triantafilou, K, Takada, Y, &
Triantafilou, M: Mechanism of
integrin – mediated virus attachment and internalization
process. Crit Rev Immunol
2001, 21:311322.[PubMed]
- Gavrilovskaya, IN, Brown, EJ, Ginsberg,
MH, & Mackow, ER: Cellular entry
of hantavirus which cause hemorrhagic fever with renal syndrome is
mediated by beta3 integrins. J
Virol 1999, 73:39513959.
- Ling, WL, Longley, RL, Brassard, DL,
Armstrong, L, & Schaefer, EJ: Role of integrin alphavbeta3 in the production of
recombinant adenovirus in HEK – 293 cells. Gene Ther 2002, 9:907914.[PubMed][Full
Text]
- De Meester, I, Korom, S, Van Damme, J,
& Scharpe, S: CD26, let it cut or
cut it down. Immunol Today
1999, 20:367375.
- Ohtsuki, T, Tsuda, H, & Morimoto,
C: Good or evil: CD26 and HIV
infection. J Dermatol Sci
2000, 22:152160.[PubMed][Full
Text]
- Pohlmann, S, Baribaud, F, & Doms,
RW: DC-SING and DC-SIGNR: helping
hands for HIV. Trends
Immunol 2001, 22:643646.[PubMed][Full
Text]
- Halary, F, Amara, A, Lortat-Jacob, H,
Messerle, M, Delauncy, T, et
al. : Human Cytomegalovus
binding DC- SIGN is required for dendritic cell infection and
target cell trans-infection. Immunity 2002, 17:653664.[PubMed]
- Simmons, G, Reeves, JD, Grogan, GC,
et al. : DC-SIGN and DC-SIGNR bind ebola glycoproteins and
enhance infection of macrophages and endothelial cells.
Virology 2003, 305:115123.[PubMed][Full
Text]
- Rassa, JC, Meyers, JL, Zhang, Y,
Kudaravalli, R, & Ross, SR: Murine retroviruses activate B cells via
interaction with toll-like receptor 4. Proc Nat Acad Sci USA 2002, 99:22812286. [ Free Full text
in PMC]
- Haeberle, HA, Takizawa, R, Casola, A,
Brasier, AR, Dieterich, HJ, Van Rooijen, N, Gatalia, Z, &
Garofalo, RP: Respiratory syncytial
virus – induced activation of NF-kappaB in the lung involves
alveolar macrophages and toll-like receptor 4 – dependent
pathways. J Infect Dis 2002, 186:11991206.[PubMed][Full
Text]
- Philips, DR, Charo, IF, &
Scarborough, RM: GPIIb – IIIa: the
responsive integrin. Cell
1991, 65:359362.[PubMed]
- Weerasinghe, D, McHugh, KP, Ross, FP,
Brown, EJ, & Gisler, RH: A role
of the αvβ3 integrin in the transmigration of monocytes.
J Cell Biol 1998, 142:595607.[PubMed][Free
Full Text]
- Trikha, M, Zhou, T, Timar, J, Raso, E,
Kennel, M, Emmel, E, & Nakada, MT: Multiple roles for platelet GPIIb/IIIa and
alphavbeta3 integrins in tumor growth, angiogenesis, and
metastasis. Cancer Res 2002, 62:28242833.[PubMed][Full
Text]
- Trikha, M, Raso, E, Cai, Y, et al. : Role of alphaIIbbeta3 integrin in prostate cancer
metastasis. Prostate 1998, 15:185192.[PubMed][Full
Text]
- Andre, P, Prasad, KSS, Denis, CV, He,
M, Papalia, JM, Hynes, RO, Phillips, DR, & Wagner, DD:
CD40L stabilizes arterial thrombi by a β3
integrin – dependent mechanism. Nature Med 2002, 8:247252.[PubMed][Full
Text]
- Biancone, L, Cantaluppi, V, &
Camussi, G: CD40-CD40L interactions
in experimental and human disease (review). Int J Mol Med 1999, 3:343353.[PubMed]
- Andre, P, Nannizzi-Alaimo, L, Prasad,
SK, & Phillips, DR: Platetet –
derived CD40L. The switch-hitting player in cardiovascular
disease. Circulation 2002, 106:896899.[PubMed][Full
Text]
- Gitis, V, Adin, A, Nasser, A, Gun, J,
& Lev, O: Fluorescent dye labeled
bacteriophages – a new tracer for the investigation of viral
transport in porous media. Water
Res 2002, 36:42274234.
- Lefkovits, J, Plow, EF, & Topol,
EJ: Mechanisms of disease: platelet
glycoprotein IIb/IIIa receptors in cardiovascular medicine.
N Engl J Med 1995, 332:15531559.[PubMed][Full
Text]
- Nair, S, Ghosh, K, Kulkarni, B, Shetty,
S, & Mohanty, D: Glanzmann's
thrombastenia: updated. Platelets 2002, 13:387393.[PubMed][Full
Text]
- Brassard, DL, Maxwell, E, Malkowski, M,
Nagabhushan, TL, Kumar, CC, & Armstrong, L: Integrin alpha(v)beta(3)-mediated activation of
apoptosis. Exp Cell Res
1999, 251:3345.[PubMed][Full
Text]
- Massberg, S, Brand, K, Gruner, S, et al. : A critical role of platelet adhesion in the
initiation of atherosclerotic lesion formation. J Exp Med 2002, 196:887896.[PubMed][Full
Text]
- Elson, CO & Cong, Y: Understanding immune-microbial homeostasis in
intestine. Immunol Res 2002, 26:8794.[PubMed][Full
Text]
- Dom, RW & Trono, D: The plasma membrane as a combat zone in the HIV
battlefield. Genes Dev 2000, 14:26772688.[PubMed][Free
Full Text]
- Levy, JA: Is HIV superinfection worrisome? Lancet 2003, 361:9899.[PubMed][Full
Text]
- Marteau, P, Seksik, P, & Jian,
R: Probiotics and health: new facts
and ideas. Curr Opin
Biotechnol 2002, 13:486489.[PubMed][Full
Text]
- Cross, MC: Microbes versus microbes: immune signals generated
by probiotic lactobaccilli and their role in protection against
microbial pathogens. FEMS Immunol
Med Microbiol 2002, 34:245253.[PubMed][Full
Text]
| |